Spontaneous Esophageal Perforation in a Patient with Mixed Connective Tissue Disease by Lyman, David
138 The  Open  Rheumatology  Journal, 2011, 5, 138-143   
 
  1874-3129/11  2011 Bentham Open 
Open Access 
Spontaneous Esophageal Perforation in a Patient with Mixed Connective 
Tissue Disease 
David Lyman
* 
Cherry Street Health Services, 100 Cherry Street SE, Grand Rapids, Michigan, 49053, USA 
Abstract: Spontaneous esophageal perforation is a rare and life-threatening disorder. Failure to diagnosis within the first 
24-48 hours of presentation portends a poor prognosis. A patient with mixed connective tissue disease (MCTD) on low-
dose prednisone and methotrexate presented moribund with chest and shoulder pain, a left hydropneumothorax, 
progressive respiratory failure and shock. Initial management focussed on presumed community acquired pneumonia 
(CAP) in a patient on immunosuppressants. Bilateral yeast empyemas were treated and attributed to immunosuppression. 
On day 26, the patient developed mediastinitis, and the diagnosis of esophageal perforation was first considered. A review 
of the literature suggests that the diagnosis and management of spontaneous esophageal perforation could have been more 
timely and the outcome less catastrophic. 
Keywords: Esophageal perforation, spontaneous esophageal perforation, mixed connective tissue disease. 
  On 12 29 08, a 61-year-old family physician presented to 
the ED of his community hospital with a 12-hour history of 
left posterior shoulder pain. He had recently examined many 
children with viral URI symptoms and had experienced 
chills earlier that day. While waiting to be seen, he felt light 
headed, sat down and lapsed into a coma. 
PMH  
  1) Mixed connective tissue disease (MCTD) diagnosed in 
2007 both clinically (swollen fingers, synovitis, myalgias, 
Raynaud’s phenomenon) and serologically (high-titer 
speckled ANA, positive anti-RNP, negative anti-SCL-70). 
Patient maintained on 10mg prednisone daily, 25mg SC 
methotrexate weekly and weekly leucovorin. A recent 
cardiac catheterization for suspected pulmonary hypertension 
was normal. 2) Lumbar and thoracic spondylosis with 
degenerative arthritis of both acromioclavicular joints.   
3) Herpes Zoster (S1-S2 dermatome) in May 2008. 4) Nissen 
fundoplication and sub-selective vagotomy in1992 for 
intractable esophageal reflux and recurrent GI bleed. 
SH  
  Non-drinker, non-smoker, married for 35 years, 2 
college-aged children. He had recently discontinued 
obstetrical care because the MCTD and Raynaud’s syndrome 
interfered with the use of his hands. 
MEDICATIONS 
  As above, plus hydrocodone10mg/325mg APAP and 
ketoprofen for pain, tetracycline 500mg BID for scalp acne, 
and Diltiazem 360mg daily for Raynaud’s. 
PE 
  He appeared in good health but was agitated, confused, 
diaphoretic, tachypneic, and on nasal oxygen (SaO2 of 
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99%). He was afebrile, pulse 100, normal BP. Decreased 
breath sounds in the lower left chest. No subcutaneous 
emphysema, no clubbing of digits, and no inflammatory 
arthritic changes. While in the emergency room, the patient 
received a total of 9mg hydromorphone IM/IV for refractory 
chest pain. 
CRITICAL LABS 
  ABG pH 7.24, pCO2 57, 02 saturation 95% on 6 LPM 
nasal oxygen. AP scout film (Fig. 1) was diagnostic. CTA 
(computed tomography arteriography) showed no PE, a 
small (15%) left pneumothorax, mild pulmonary edema, a 
small left pleural effusion, no airspace consolidation or 
aortic dissection. 
HOSPITAL COURSE 
  The patient was transferred to a nearby tertiary care 
hospital with the diagnosis of community-acquired 
pneumonia (CAP) and altered mental status. Narcan was 
given upon admission with no improvement. Ceftriaxone, 
azithromycin, and stress-doses of hydrocortisone were 
administered. On day 2 (12/30/09), a second CT showed a 
complex left hydropneumothorax and LLL consolidation. He 
rapidly deteriorated and was intubated for acute respiratory 
failure, progressive encephalopathy and septic shock 
requiring pressors and drotrecogin alfa. Antibiotics were 
changed to vancomycin and levofloxacin. A thoracentesis 
revealed hyphae, and anidulafungin was added. Blood and 
sputum cultures were negative. Pleural fluid cultures grew 
out  Candida albicans only. The differential diagnosis was 
fungal versus CAP with empyema, septic shock, and 
multisystem organ failure (MSOF) including renal failure, 
encephalopathy, and acute respiratory failure. On day 11 
(1/8/09), a left thoracotomy with decortication removed an 
extensive empyema peel. The surgeon described immediate 
reexpansion of viable lung. Postoperatively, a new right 
pleural effusion developed. Diagnostic thoracentesis grew 
Candida  albicans,  Candida  lusitaniae, Lactobacillus, and 
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(esophagogastroduodenoscopy) for an UGI bleed revealed a 
small esophageal erosion with no ulceration or esophagitis 
and a benign gastric ulcer. Over the next week, the patient 
failed to improve despite aggressive tube thoracostomy 
drainage and multiple antimicrobials. On day 26 (1/23/09), 
the radiologist observed interval CT changes (Fig. 2) not 
present on 1/6/09 and barely visible on 1/15/09 - the day 
before the EGD. A diagnostic test was suggested and 
performed later that evening. 
 
 
CME QUESTIONS: 
 
What CT abnormality did the radiologist observe? 
A.  Free air in the abdomen 
B.  Gas in the mediastinum 
C.  A mediastinal shift 
 
What procedure or test would be diagnostic? 
A.  A ventilation-perfusion scan 
B.  A Gastrografin esophagram 
C.  A right heart catheterization 
________________________________________________ 
 
Fig. (1). Admitting AP scout film. 
 
Fig. (2). Giménez A, Franquet T, Erasmus JJ, Martínez S, Estrada P. Thoracic complications of esophageal disorders. Radiographics. 2002 
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CASE MANAGEMENT 
  CT scan showed mediastinal gas (arrow) with bilateral 
pleural effusions. The evolving mediastinal process was 
consistent with an esophageal perforation, and the radiologist 
suggested a Gastrografin esophagram. A small outpouching 
was noted at the distal esophagus, and a limited chest CT 
confirmed the extravasation of barium into both left and 
right pleural spaces. Later that evening (day 26 of 
hospitalization), the patient underwent a right thoracotomy 
and decortication. Despite meticulous debridement of 
necrotic mediastinal debris, the esophageal perforation was 
never identified and biopsies for histology were not 
obtained. The suspected area was approximated with parietal 
pleura and intercostal muscle. The patient remained NPO, 
and spontaneous closure of the perforation was documented 
by serial esophageal CTs. 
  One month later, the patient no longer required oxygen 
and was transferred to a rehabilitation facility for treatment 
of critical illness myopathy. Four months after presenting in 
septic shock, the patient was discharged home using a 
walker, receiving outpatient physical therapy, low-dose 
prednisone, and extended-release morphine for pain. At 2 
years, arthritis pain with residual proximal muscle weakness 
and moderate-to-severe restrictive lung disease limit all 
activities. 
DIAGNOSIS OF SPONTANEOUS ESOPHAGEAL 
PERFORATION 
  Spontaneous rupture of the thoracic esophagus is rare and 
life threatening. Patients who sustain a transmural laceration 
of the esophagus can present with clinically stable chest pain 
or arrive moribund with no obvious diagnosis. Only rarely 
does a patient present with the classic triad of vomiting, 
sudden epigastric pain and shock - Boerhaave’s syndrome. 
The diagnosis is often delayed or missed entirely. Few 
studies have looked critically at time-to-diagnosis or time-to-
treatment. Griffin et al., calculated the median delay from 
admission to diagnosis was 24 hours, with a range of 4 hours 
to 604 hours. Jougon et al., calculated a mean delay-to-
treatment of 2 days, but the longest delay was 40 days. Some 
authors report a lower mortality rate if the injury is 
diagnosed within 24 to 48 hours of presentation, but this 
observation is controversial. (see below) [1, 2] 
  Definitive diagnosis is challenging. Because the majority 
of patients report pain somewhere in the thoracic region, a 
chest x-ray (CXR) or computed tomography (CT) of the 
chest is often ordered as the initial imaging modality. 
Abnormalities suggestive of perforation include a pleural 
effusion,  pneumothorax,  pneumomediastinum, or 
mediastinitis. These abnormalities may not appear for 
several hours - while the patient becomes increasingly 
unstable. Early Gastrografin esophagography may identify 
the perforation, although the results are falsely negative in 
15% to 25% of studies. If clinical suspicion remains high, 
radiologists recommend helical CT esophagography to 
improve the sensitivity of contrast-enhanced esophageal 
radiography [3, 4]. 
  The esophagus deviates to the left to enter the esophageal 
hiatus, placing the left lateral wall in direct contact with the 
mediastinal pleura. For this reason, 70% of pleural lesions 
present on the left. When the mediastinal parietal pleura are 
breached, a left  hydropneumothorax,  pyopneumothorax, or 
empyema develops. Bilateral empyemas soon appear if the 
diagnosis of perforation is delayed [5]. 
  Empyema pH of <6.0 early in the course of an acute 
illness suggests an esophageal perforation. Although chronic, 
well-localized empyemas can occasionally have pH values of 
<6.0, such a level would not be expected to occur in newly 
formed lesions. The distinction is critical: mortality may 
approach 50% if treatment of esophageal perforation is 
delayed by 24 hours or more [6]. 
TREATMENT OF THORACIC ESOPHAGEAL 
PERFORATION 
  Consensus on best treatment is limited by the 
heterogeneity of patients upon presentation. Some patients 
present in septic shock requiring intubation and inotropic 
support, while others present with minimal signs of sepsis. 
Reported mortality rates range from 10% to 50% regardless 
of the timing of surgical intervention. Nonetheless, most 
authors advise primary repair of the perforated thoracic 
esophagus if the diagnosis is confirmed within 24 hours of 
admission - with the caveat that survival and early 
intervention may have an inverse relationship. This 
observation has been termed selection bias: the patient with 
less contamination may tolerate a longer diagnostic delay 
than the patient who presents moribund but is rapidly 
diagnosed. Conversely, associated comorbidities (sepsis, 
respiratory failure, cardiac complications, empyema, renal 
failure) may contribute to the increased mortality observed 
when definitive treatment is delayed [2, 4, 6-8]. 
  Aggressive non-operative management has been 
proposed as one treatment option, especially when the 
rupture has been contained by the mediastinal pleura [1, 4, 
8]. Iatrogenic perforation during endoscopy may be best 
treated with either conservative or interventional (i.e., stent 
placement) therapy. Spontaneous rupture of the esophagus is 
associated with more extensive mediastinal/pleural 
contamination. These patients present with septic shock and 
MSOF, and are more likely to require surgery [1, 8]. 
However, there is no general agreement on treatment if the 
diagnosis is delayed and the patient is tolerating 
pleural/mediastinal drainage. Vogel, et al., observed that 
esophagocutaneous fistula via chest tube healed as well as 
other gastrointestinal fistulas - an enthusiasm not shared by 
most authors [4]. Griffin, et al., observed that a delayed 
primary esophageal repair was more likely to leak, and 
suggested repair over a T-tube to create a controlled 
esophagocutaneous fistula [1]. Conversely, Kiev, et al., and 
others note that surgical repair can be safely offered even 
when the diagnosis is delayed [2, 8]. 
  In 2009, Vallböhmer, et al., published their experience 
with lower esophageal perforation, and reviewed the 
outcomes of 12 previous publications. The authors conclude 
that treatment of a lower esophageal perforation may be 
individualized depending on the etiology, location, and size 
of the perforation. A stable patient who presents with an 
iatrogenic perforation may be safely observed and offered 
the most appropriate treatment - conservative, interventional, 
or surgical. The patient who presents acutely ill with a 
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contamination is more likely to undergo aggressive surgical 
therapy. Surgery within 24 hours of diagnosis has an 
observed mortality rate of 14% compared to 27% when 
treatment is delayed for 24 hours or more. Perhaps the most 
critical issue is the timely elimination of a septic focus. The 
authors found no consensus on best treatment for the septic 
patient: aggressive pleural/mediastinal drainage with stenting 
or definitive surgical debridement with primary repair each 
have their advocates [9]. 
  Also in 2009, de Schipper et al., reviewed the literature 
from 1975 to 2008, and concluded that existing data was 
limited to either retrospective tertiary care center reviews or 
expert opinion with significant publication bias regardless of 
management - whether conservative, endoscopic, or 
operative. His group proposed the following algorithm for 
future prospective studies: operative treatment should be 
offered to the patient diagnosed with lower esophageal 
perforation within the first 24-48 hours; conservative 
treatment should be recommended if diagnosed after 48 
hours, with conversion to operative treatment if the patient 
becomes septic. In the absence of extensive tissue necrosis, 
primary repair offers acceptable results with the shortest 
hospitalization. Resection and reconstruction may be 
necessary if the surgeon encounters extensive necrosis or 
distal obstruction. Diversion with proximal and distal 
esophageal exclusion may be the only option for the patient 
too ill to tolerate more extensive surgery [10]. 
WHY WAS ESOPHAGEAL PERFORATION NOT 
DIAGNOSED FOR 26 DAYS IN THE CASE 
PRESENTED? 
Pulmonary Consolidation was Attributed to Community-
Acquired Pneumonia 
  The diagnosis of CAP is based on certain clinical features 
(e.g., cough, fever, sputum production, pleuritic chest pain) 
supported by imaging of the lung. Rarely, CAP may present 
with atypical radiologic findings: hydropneumothorax with 
pulmonary consolidation has been reported [11]. However, 
neither the clinical presentation nor the initial radiologic 
findings suggested CAP, and were more consistent with the 
diagnosis of spontaneous esophageal perforation - a rare 
diagnosis not considered until much later [3-5]. 
  Pleural effusion complicates up to 44% of patients with 
CAP, and 10% develop a complicated parapneumonic 
effusion or empyema [12]. In the case presented, bilateral 
empyemas were aggressively treated, although the cause of 
the suspected pneumonia was never identified. This by itself 
is not alarming: the causative organism in CAP cannot be 
determined in 50% of cases [13]. 
  Rapid pleural fluid accumulation resulted in near-
complete consolidation of the left lower lobe (LLL) within 
hours. By day 3, radiology was using the terms 
“consolidation,” “atelectasis” and “pneumonia” 
interchangeably. Contrast enhanced chest CT may help 
differentiate atelectasis from pneumonia [14]. On day 10, 
chest CT with contrast was obtained, and the radiologist 
described “near-complete atelectasis of the LLL” with no 
bronchial obstruction and no lobar pneumonia. 
 
The Degree of Immunosuppression was Overestimated 
  Infections account for more than 50% of ICU admissions 
for patients with systemic rheumatic disorders [15]. The 
isolation of Candida albicans and Candida lusitaniae from 
pleural fluid was attributed to the patient’s use of prednisone 
(10mg PO daily) and methotrexate (25mg SC weekly) for 
mixed connective tissue disease. Candida pneumonia does 
occur in severely immunocompromised patients but is a 
difficult diagnosis to establish: Candida is a common 
colonizer in this patient population. However, CT findings 
presented were not compatible with Candida pneumonia - an 
infection that presents with multiple, bilateral pulmonary 
nodules and consolidation [14]. 
  Was the patient immunocompromised? Lisboa, et al., 
followed the hospital course of 457 patients admitted to the 
ICU with severe CAP. Patients were considered 
immunosuppressed only if they were receiving radiation 
therapy or chemotherapy, if they had HIV/AIDS, of if they 
received more than 20mg of prednisolone daily for at least 2 
weeks [16]. There are authors who suggest that the 
simultaneous use of corticosteroids and immunosuppressive 
drugs to treat certain connective tissue diseases may increase 
the risk for infection [17]. Wolfe followed 16,788 
rheumatoid patients who were assessed semiannually for 3.5 
years. He observed a dose-dependent risk for being 
hospitalized with pneumonia in patients who received less 
than 20mg of prednisone daily: at a dose of 5-10mg/day, the 
hazard ratio (HR) is 2.1 [95% confidence interval 1.7-2.7]; at 
a dose over 10 mg/day, the HR is 2.3 [95% confidence 
interval 1.6-3.2] [18]. The HR for infliximab, adalimumab, 
and methotrexate were not significantly different from zero 
[18]. However, there are no large-scale studies that compare 
the use of immuno-suppressive drugs and the prevalence of 
infections in MCTD [17]. 
Empyema Occurs in the Absence of Pneumonia 
  Empyema most commonly develops after pneumonia 
(40% to 60% of cases) but is also caused by trauma, surgery, 
subdiaphragmatic infection, hematologic spread, rupture of 
an intrapulmonary abscess, and esophageal perforation [19, 
20]. Mandell et al., in Consensus Guidelines on the 
Management of Community-Acquired Pneumonia in Adults, 
state that the failure of CAP to respond to appropriate 
treatment suggests either an impaired host response (i.e., 
immunosuppression) or an extrapulmonary process [20]. The 
early isolation of two species of Candida ( albicans and 
lusitaniae) from empyema fluid was aggressively treated, but 
attributed to either immunosuppression or contamination. In 
fact, the patient never had pneumonia: Candida empyema 
without pneumonia has been described as a complication of 
surgery, subdiaphragmatic infection, candida sepsis, and 
esophageal rupture [21]. The search for esophageal 
perforation should have begun in earnest once the diagnosis 
of fungal pneumonia was dismissed. 
  Successful empyema treatment demands aggressive 
pleural drainage and complete lung re-expansion. As the 
empyema matures, turbid fluid begins to loculate and fibrin 
deposition occurs on both visceral and parietal pleurae. The 
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entrapment, and tube thoracostomy may no longer provide 
adequate pleural drainage. Open thoracotomy with empyema 
evacuation and pulmonary decortication is required to resect 
the empyema “peel” and release collapsed lung. Failure to 
diagnose esophageal perforation as the source of 
pleural/mediastinal soilage has disastrous consequences, as 
demonstrated by the rapid reaccumulation of empyema fluid 
on the right following decortication on the left lung [19, 21]. 
DISCUSSION 
  The vast majority of perforations are either traumatic 
(iatrogenic or barogenic), inflammatory, or neoplastic. True 
spontaneous perforations account for a small minority [5, 
22]. GERD-related esophageal perforations are very rare but 
can cause mediastinitis and death [23]. The patient had a 
history of GERD, but endoscopy was negative for erosive 
esophagitis. Esophageal dysmotility is common in MCTD, 
although esophageal perforation has never been reported. 
Among the spectrum of collagen vascular diseases, 
esophageal perforation has only been described as a rare 
complication of dermatomyositis and in Behcet’s disease 
with aphthous esophageal ulcerations [24]. These overlap 
findings were not noted during the patient’s prolonged 
hospitalization, and the correct diagnosis eluded physicians 
for nearly a month. 
  Delayed or missed diagnoses are common in the practice 
of medicine. Schiff, et al., reviewed 583 physician-reported 
errors: 44% occurred during the testing phase and 32% 
occurred because the clinician failed to consider a 
compelling alternative diagnosis [25]. The rapid expansion 
of medical knowledge is a daily challenge for physicians 
who attend critically ill patients. When the diagnosis is 
unclear, Tang and Ng demonstrated (in 2006) and Ebell 
reiterated (2009) the value of using Google as a search 
engine. Google now indexes the National Library of 
Medicine and may provide access to older articles released to 
the public domain [26, 27]. Had the patient’s presenting 
symptoms and findings (pneumothorax, hydrothorax, 
shoulder pain, shock) been entered as a Google search, one 
of the early results was Dr.  Anderson’s 1957 article, 
“Spontaneous Rupture of the Esophagus.” [28] The results of 
any search depend upon how the terms are entered or 
arranged, but esophageal perforation is always noted. 
SUMMARY 
  The optimal management of esophageal perforation 
remains controversial. Patient morbidity and mortality 
depend upon the experience of the managing physicians and 
institutional clinical resources [22]. In the case presented, 
failure to consider a rare diagnosis in spite of numerous 
compelling findings delayed appropriate and timely 
intervention. One, the diagnosis of esophageal perforation 
must be considered when a moribund patient presents with a 
history of chest (or shoulder) pain and is found to have a left 
hydropneumothorax. Two, community acquired pneumonia 
does not present with bilateral empyemas and massive 
pulmonary consolidation from compressive atelectasis. 
Three, immunosuppression is relative: the differential 
diagnosis of any pulmonary process in a patient with a 
connective tissue disorder on low-dose prednisone and 
methotrexate should include both infectious and non-
infectious entities. Lastly, Candida empyema without 
pneumonia is a well-described complication of esophageal 
perforation. 
“When you have eliminated the impossible, 
whatever remains, however improbable, must 
be the truth.”  
(Sir Arthur Conan Doyle in Sherlock Holmes) 
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